Enlivex Therapeutics
ENLV
ENLV
2 hedge funds and large institutions have $219K invested in Enlivex Therapeutics in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$17.6K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$11K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $219K | +$17.6K | +1,423 | +9% |
|
|
VF
2
Virtu Financial
New York
| – | -$11K | -1,763 | Closed |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$4K | -615 | Closed |
|